4DMEDICAL Ltd Market Cap ($872.88 Million)
Market Cap & Net Worth: 4DMEDICAL Ltd (4DX)
4DMEDICAL Ltd market cap. 4DMEDICAL Ltd (AU:4DX) has a market capitalization of $872.88 Million (AU$1.23 Billion) as of November 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #9197 globally and #224 in its home market, demonstrating a -40.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 4DMEDICAL Ltd's stock price AU$2.15 by its total outstanding shares 573784088 (573.78 Million). Also see 4DMEDICAL Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
4DMEDICAL Ltd Market Cap History (2020–2026)
4DMEDICAL Ltd market cap history from 2020 to 2026. Data shows growth from $986.55 Million to $872.88 Million (4.95% CAGR). Check 4DMEDICAL Ltd (4DX) stock price for real-time trading data and today's change.
Index Memberships
4DMEDICAL Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P/ASX All Technology
AXTX
|
$108.30 Billion | 0.81% | #16 of 53 |
Weight: 4DMEDICAL Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
4DMEDICAL Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 4DMEDICAL Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 4DMEDICAL Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
272.58x
4DMEDICAL Ltd's market cap is 272.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $986.55 Million | $216.98K | -$21.42 Million | 4546.79x | N/A |
| 2021 | $548.08 Million | $1.05 Million | -$24.59 Million | 519.86x | N/A |
| 2021 | $548.08 Million | $216.98K | -$21.42 Million | 2525.99x | N/A |
| 2022 | $170.52 Million | $718.58K | -$31.46 Million | 237.29x | N/A |
| 2022 | $170.52 Million | $1.05 Million | -$24.59 Million | 161.73x | N/A |
| 2023 | $290.28 Million | $3.75 Million | -$35.98 Million | 77.32x | N/A |
| 2023 | $290.28 Million | $718.58K | -$31.46 Million | 403.97x | N/A |
| 2024 | $194.87 Million | $5.85 Million | -$30.07 Million | 33.29x | N/A |
| 2024 | $194.87 Million | $3.75 Million | -$35.98 Million | 51.91x | N/A |
| 2025 | $1.60 Billion | $5.85 Million | -$30.07 Million | 272.58x | N/A |
Competitor Companies of 4DX by Market Capitalization
Companies near 4DMEDICAL Ltd in the global market cap rankings as of November 6, 2026. Also see 4DX total assets for a full breakdown of the balance sheet.
Key companies related to 4DMEDICAL Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of 4DMEDICAL Ltd (2020–2026)
Market capitalization of 4DMEDICAL Ltd from 2020 to today. Between 2020 and today, 4DMEDICAL Ltd's market cap moved from $986.55 Million to $ 872.88 Million, with a yearly change of 4.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$872.88 Million | -45.29% |
| 2025 | AU$1.60 Billion | +718.75% |
| 2024 | AU$194.87 Million | -32.87% |
| 2023 | AU$290.28 Million | +70.24% |
| 2022 | AU$170.52 Million | -68.89% |
| 2021 | AU$548.08 Million | -44.44% |
| 2020 | AU$986.55 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of 4DMEDICAL Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $872.88 Million USD |
| MoneyControl | $872.88 Million USD |
| MarketWatch | $872.88 Million USD |
| marketcap.company | $872.88 Million USD |
| Reuters | $872.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About 4DMEDICAL Ltd
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more